Enhancer of zeste homolog 2 is a histidine-lysine N-methyltransferase. This enzyme plays an important role in histone methylation and transcriptional repression, and it can modulate downstream target gene expression through trimethylation of Lys-27 in histone 3 (H3K27me3). EZH2 interacts directly with other proteins to activate downstream genes in a manner that is independent of PRC2. Mutations or over-expression of EZH2 are associated with many forms of cancer, and EZH2 inhibitors are able to induce cell cycle arrest, apoptosis and cell differentiation in cells, as well as induction of genes involved in cell cycle regulation, apoptosis and neuronal-like differentiation. Thus, EZH2 enables to inhibit genes responsible for suppressing tumor development, and blocking its activity may slow down tumor growth. EZH2 is an attractive target for anticancer therapy.
In order to develop potent EZH2 inhibitors, BOC Sciences offers an enhancer of the EZH2 targeted library. It contains 979 compounds with predicted inhibitory activity against this enzyme.
Figure 1.A model depicting mechanism of overexpression of EZH2 in ovarian cancer and its role in regulating gene expression. (Jones, B.; et al. 2018)
BOC Sciences has combined various ligand-based virtual screening approaches to design the EZH2 target library.
The combination of artificial neural networks, Bayesian statistics, k-NN and pharmacophore modeling allows increasing the number of active compounds identified during the screening process
BOC Sciences provides professional, rapid and high-quality services of Histone Methyltransferase EZH2 Targeted Library design at competitive prices for global customers. Personalized and customized services of Histone Methyltransferase EZH2 Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.